Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May 29;13(11):1898.
doi: 10.3390/diagnostics13111898.

Elastography of the Liver in Wilson's Disease

Piotr Nehring  1 , Jowita Szeligowska  1 , Adam Przybyłkowski  1
Affiliations
Review

Elastography of the Liver in Wilson's Disease

Piotr Nehring et al. Diagnostics (Basel). .

Abstract

Staging of liver fibrosis is of special significance in Wilson's disease as it determines the patient's prognosis and treatment. Histopathological examination is a standard method for fibrosis assessment; however, non-invasive methods like transient elastography and share wave elastography are believed to be reliable and repetitive and are expected to replace liver biopsy in Wilson's disease. This article presents a short description of available elastography techniques and the results of the most recent studies on elastography of the liver in patients with Wilson's disease.

Keywords: Wilson’s disease; elastography; fibrosis; liver; non-invasive.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Socha P., Janczyk W., Dhawan A., Baumann U., D’Antiga L., Tanner S., Iorio R., Vajro P., Houwen R., Fischler B., et al. Wilson’s Disease in Children: A Position Paper by the Hepatology Committee of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. J. Pediatr. Gastroenterol. Nutr. 2018;66:334–344. doi: 10.1097/MPG.0000000000001787. - DOI - PubMed
    1. Boga S., Ala A., Schilsky M.L. Hepatic features of Wilson disease. Handb. Clin. Neurol. 2017;142:91–99. doi: 10.1016/b978-0-444-63625-6.00009-4. - DOI - PubMed
    1. Arai S., Kogiso T., Ogasawara Y., Sagawa T., Taniai M., Tokushige K. Long-term outcome of Wilson’s disease complicated by liver disease. JGH Open. 2021;5:793–800. doi: 10.1002/jgh3.12589. - DOI - PMC - PubMed
    1. Mazi T.A., Shibata N.M., Medici V. Lipid and energy metabolism in Wilson disease. Liver Res. 2020;4:5–14. doi: 10.1016/j.livres.2020.02.002. - DOI - PMC - PubMed
    1. Zhi Y., Sun Y., Jiao Y., Pan C., Wu Z., Liu C., Su J., Zhou J., Shang D., Niu J., et al. HR-MS Based Untargeted Lipidomics Reveals Characteristic Lipid Signatures of Wilson’s Disease. Front. Pharmacol. 2021;12:754185. doi: 10.3389/fphar.2021.754185. - DOI - PMC - PubMed

LinkOut - more resources